ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Effective tax rate (%)

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.1B
P/E ratio
39.9x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Mar 31, 2025-9.3-196.52%
Mar 31, 20249.6-96.06%
Mar 31, 2023243.1+803.46%
Mar 31, 202226.9-28.16%
Mar 31, 202137.5-61.15%
Mar 31, 202096.4+154.86%
Mar 31, 201937.8+4.16%
Mar 31, 201836.3+30.16%
Mar 31, 201727.9-16.57%
Mar 31, 201633.4-9.88%
Mar 31, 201537.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat